SANTA BARBARA, CALIFORNIA—(February 7, 2018) – USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, announces Jay Crowley will speak at MD&M West 2018 in Anaheim, CA, February 6-8.
What: Panel - Next Steps for Implementing Global UDI
Who: Jay Crowley, VP of UDI Services and Solutions at USDM Life Sciences
Where: MD&M West 2018, Anaheim Convention Center
When: Wednesday, February 7, 2:30-4:00 pm
“I am looking forward to facilitating some critical discussions surrounding the global UDI requirements and sharing my experiences with UDI in the United States,” said Crowley. “This event comes at a critical time for the medical device industry as the first MDR/IVDR deadlines approach and more countries around the world move towards implementing UDI regulations.”
The Unique Device Identification (UDI) system offers a number of benefits that will be more fully realized with the adoption and integration of UDIs into the healthcare delivery system. UDI implementation will improve patient safety, modernize device postmarket surveillance, and facilitate medical device innovation. But questions remain. This session will attempt to clear the air.
Topics to be covered include:
- FDA’s issues regarding UDI, recent changes, and emphasis on data quality
- Effects of UDI in the EU, which has just included this in its new regulations
- UDI in Canada, Brazil, China, Taiwan, Korea, Japan, and other locations
Jay Crowley, VP of UDI Services and Solutions at USDM Life Sciences was most recently Senior Advisor for Patient Safety in the Food and Drug Administration’s Center for Devices and Radiological Health. Jay developed the framework and authored key requirements for FDA’s Unique Device Identification system. His extensive tenure in the regulated life sciences industry has allowed him to assist medical device companies in meeting ever-changing UDI compliance standards.
At USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage with UDI implementation and MDR/IVDR guidance. Topics to be covered in the panel include FDA’s issues regarding UDI, recent changes, and emphasis on data quality, Effects of UDI in the EU and UDI in Canada, Brazil, China, Taiwan, Korea, Japan, and other locations.
About USDM Life Sciences:
USDM Life Sciences is a global life science and healthcare services company, providing strategy and compliant technology solutions to regulated industries. If you work in Life Sciences or Healthcare, partnering with USDM Life Sciences makes it easy to accelerate innovation and maximize productivity. USDM Life Sciences only focuses on regulated industries and has built trusted partnerships with the most innovative technology companies in the world, and boast a staff of industry leading experts in the areas of technology and compliance. USDM Life Sciences is doing business as USDM Europe GmbH in Germany.
USDM Life Sciences